The Latest Cardiac and Vascular News
Physician-only event, organized by the University of Pennsylvania, is a tribute to the pioneer of cardiac electrophysiology Westport, CT, Aug. 31, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and […]
– New data presented at ESC Congress 2021 and simultaneously published in Circulation show Amulet Occluder was superior in left atrial appendage (LAA) closure and noninferior on safety and effectiveness endpoints compared to Watchman device – Amulet device is the first and only minimally invasive option approved for LAA occlusion […]
ST. LOUIS and SHANGHAI, China, Aug. 30, 2021 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS) and Shanghai Microport EP Medtech Co., Ltd. (“MicroPort EP”) today announced a broad collaboration to advance technology innovation and commercial adoption of robotics in electrophysiology in China. The agreement brings together MicroPort EP’s commercial and product leadership in […]
Results Presented at ESC 2021 Show Micra TPS Compares Favorably to Traditional Pacemakers DUBLIN, Aug. 27, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced new data from the Micra Coverage with Evidence Development (CED) Study, the largest evaluation of leadless pacemakers to date, which showed the Micra™ Transcatheter Pacing […]
– In this clinical first for adults with heart failure with preserved ejection fraction, Jardiance demonstrated an impressive 21% relative risk reduction in the composite primary endpoint of cardiovascular death or hospitalization for heart failure – The benefit in the primary endpoint was independent of ejection fraction or diabetes status […]
NEW YORK, Aug. 27, 2021 /PRNewswire/ — VEEPOO WATCH RIG, equipped with multiple health monitoring functions featuring its EKG/ECG monitoring service, can effectively detect a series of heart diseases such as atrial fibrillation and premature beat. The sampling of EKG/ECG signal frequency can reach up to 512hz, which is a medical application level. […]
Pulmonary arterial hypertension (PAH) affects almost 68,000 patients worldwide, with treatment limited to vasodilators, none of which are disease-modifying Dosing of patients in Phase 1 trial is currently ongoing Plans to enter Phase 2/3 Trials in early 2022 DURHAM, N.C., Aug. 25, 2021 (GLOBE NEWSWIRE) — Aerami Therapeutics, Inc. a […]
SEOUL, South Korea, Aug. 24, 2021 /PRNewswire/ — South Korean artificial intelligence (AI) developer, VUNO Inc. announced today that it has received regulatory approval from the Ministry of Food and Drug Safety (MFDS) for its VUNO Med®–DeepCARS™, an AI medical device for cardiac arrest prediction through vital signs. VUNO Med®–DeepCARS™ is a […]
Wearable devices accurately measure Heart Rate and RR Intervals in 180 cardiovascular at-risk patients BUSSUM, Netherlands, Aug. 24, 2021 /PRNewswire/ — Today, Corsano Health, a leading MedTech company developing, producing, and marketing medical grade continuous health monitoring devices announced the publication of a peer-reviewed clinical trial evaluating the accuracy of Heart Rate and […]
As Demand for Cardiac EP Clinicians Expands New CE Series Offers Clinicians Flexible Learning Options NORTHFIELD, Ill., Aug. 23, 2021 /PRNewswire/ — Medline ReNewal today announced the launch of a continuing education (CE) course series to help cardiac electrophysiology (EP) clinicians learn more about the fundamentals of cardiac EP lab procedures. Available through Medline, […]
